2024-21086. Medical Devices; Immunology and Microbiology Devices; Classification of the Quantitative Viral Nucleic Acid Test for Transplant Patient Management
Table 1—Quantitative Viral Nucleic Acid Test for Transplant Patient Management Risks and Mitigation Measures
Identified risks to health Mitigation measures Risk of false results Certain warnings, limitations, results interpretation information, and explanation of procedures in labeling; and Certain device descriptions and specifications, analytical studies, clinical studies, and risk analysis in design verification and validation. Failure to correctly interpret test results Certain warnings, limitations, results interpretation information, and explanation of procedures in labeling. Failure to correctly operate the device Certain warnings, limitations, results interpretation information, and explanation of procedures in labeling.
Document Information
- Effective Date:
- 9/17/2024
- Published:
- 09/17/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-21086
- Dates:
- This order is effective September 17, 2024. The classification was applicable on July 30, 2020.
- Pages:
- 75953-75955 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-4084
- Topics:
- Biologics, Laboratories, Medical devices
- PDF File:
- 2024-21086.pdf
- CFR: (1)
- 21 CFR 866